The Drug Enforcement Administration has announced a proposal to set aggregate production quotas for Schedule I and II controlled substances for the year 2027, alongside an assessment of the annual requirements for the…
A final rule issued by the Drug Enforcement Administration updates an existing regulation to state that the provision governing amendments to and withdrawal of registration applications also covers applications for…
On November 2, 2002, the Criminal Law Technical Amendments Act of 2002 was signed into law as a component of the 21st Century Department of Justice Appropriations Authorization Act. The legislation amended sections…
According to a DEA announcement, the agency plans to remove certain non‑narcotic prescription products containing butalbital from its Table of Exempted Prescription Products because their National Drug Codes are…
According to a notice referencing the Privacy Act of 1974 and OMB Circular No. A‑108, the Drug Enforcement Administration announced its intention to amend and re‑issue the system of records titled “JUSTICE/DEA‑021, DEA…
A proposed rule would amend DEA regulations to lengthen the allowable time for reexporting controlled substances outside the European Economic Area from 180 days to 365 days after the original release from U.S. Customs…
The Drug Enforcement Administration (DEA) announced that it will submit a proposed information collection request to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act. The request,…
The Drug Enforcement Administration, part of the Department of Justice, has announced a request to the Office of Management and Budget to approve a revised information collection concerning recordkeeping for partial…